EXHIBIT 10.3
------------
ACC DEAMINASE LICENSE AGREEMENT
This AGREEMENT is made this ___ day of ________, 1996, between Calgene II,
Inc., and Monsanto Company regarding the license of certain patent rights.
Based on the mutual consideration between the parties, the parties do hereby
agree as follows:
ARTICLE 1 BACKGROUND AND PARTIES
1.1 Calgene II, Inc. ("NEWCO") is a Delaware corporation, having a
principal place of business at 0000 Xxxxx Xxxxxx, Xxxxx, Xxxxxxxxxx 00000.
1.2 Monsanto Company ("MONSANTO") is a Delaware corporation, having a
principal place of business at 000 Xxxxx Xxxxxxxxx Xxxxxxxxx, Xx. Xxxxx,
Xxxxxxxx 00000.
1.3 NEWCO and MONSANTO are mutually interested in entering into a
transaction involving the licensing of certain patent and know-how rights
subject to the terms and conditions of this AGREEMENT.
ARTICLE 2 DEFINITIONS
For purposes of this AGREEMENT, the following words and phrases shall have the
following meanings:
2.1 "AFFILIATE" shall mean any company or other legal entity which
controls, or is controlled by, or is under common control with a party to this
AGREEMENT, control meaning the holding, directly or indirectly, of more than
twenty percent (20%) of (i) the capital and/or (ii) the voting rights and/or
(iii) the right to elect or appoint directors.
2.2 "AGREEMENT" shall mean this License Agreement.
2.3 "EFFECTIVE DATE OF THIS AGREEMENT" shall mean the date first above
written.
2.4 "FIELD" shall mean for use in PRODUCE PLANTS.
2.5 "PRODUCE PLANTS" shall mean fresh and processed tomatoes, berries,
mangoes, cucurbits, peppers and sweetcorn.
2.6 "LICENSED PRODUCTS" shall mean genes, vectors, PRODUCE PLANT cells,
PRODUCE PLANTS and seed thereof of PRODUCE PLANTS containing a gene which
encodes for the sense or antisense of a
gene which, in the absence of a license, would infringe at least one (1) claim
of an unexpired U.S. or foreign patent included within LICENSED PATENT RIGHTS.
2.7 "LICENSED PATENT RIGHTS" shall mean the patents and patent
applications identified in Appendix A and any continuations, continuations in
part, divisionals, or reissue or reexamination patents or applications in the
United States deriving priority from a common application with said patent
applications and any foreign counterparts thereof.
2.8 "MONSANTO KNOW HOW" shall mean all know-how and biological materials
in the FIELD related to the LICENSED PATENT RIGHTS disclosed to NEWCO at the
EFFECTIVE DATE OF THIS AGREEMENT.
2.9 "TERM OF THIS AGREEMENT" shall be for the life of the last to issue
patent in the LICENSED PATENT RIGHTS.
ARTICLE 3 CONVEYANCE OF RIGHTS
3.1 LICENSE GRANT: Subject to the terms and conditions of this AGREEMENT,
--------------
MONSANTO hereby grants to NEWCO and AFFILIATES of NEWCO under the LICENSED
PATENT RIGHTS and MONSANTO KNOW HOW and during the TERM OF THIS AGREEMENT an
exclusive, royalty-free world-wide license to make, use and sell LICENSED
PRODUCTS in the FIELD and the right to sublicense others to sell PRODUCE PLANTS.
ARTICLE 4 CONFIDENTIALITY
4.1 CONFIDENTIAL INFORMATION: It is anticipated that it will be
-------------------------
necessary, in connection with their obligations under this AGREEMENT, for NEWCO
and MONSANTO, and AFFILIATES of either party, to disclose to each other
confidential proprietary business and/or technical information ("Confidential
Information") relating to their respective businesses, products and
technologies. The Confidential Information shall include information disclosed
in writing or other tangible form, including samples of materials. If disclosed
orally, the Confidential Information shall be summarized in written form within
thirty (30) days by the disclosing party and a copy provided to the recipient.
4.2 CONFIDENTIALITY AND LIMITED USE:
--------------------------------
(a) With respect to all Confidential Information, both NEWCO and MONSANTO
and AFFILIATES of either party agree as follows, it being understood that
"recipient" indicates the party
2
receiving the confidential, proprietary information from the other "disclosing"
party. Confidential Information disclosed to the recipient shall remain the
property of the disclosing party and shall be maintained in confidence by the
recipient and shall not be disclosed to third parties by the recipient and,
further, shall not be used except for purposes contemplated in this AGREEMENT.
All confidentiality and limited use obligations with respect to the Confidential
Information shall terminate five (5) years after the termination date of this
AGREEMENT.
(b) Notwithstanding any provision to the contrary, a party may
disclose the Confidential Information of the other party: (i) in connection with
an order of a court or other government body or as otherwise required by or in
compliance with law or regulations; provided that the disclosing party provides
the other party with notice and takes reasonable measures to obtain confidential
treatment thereof; (ii) in confidence to attorneys, accountants, banks and
financial sources and their advisors; or (iii) in confidence, in connection with
a license, sublicense, or acquisition so long as, in each case, the entity to
which disclosure is made is bound to confidentiality on terms consistent with
those set forth herein.
4.3 EXCEPTIONS: The obligations of confidentiality and limited use shall
-----------
not apply to any of the Confidential Information which
(a) is publicly available by publication or other documented means or
later becomes likewise publicly available through no act or fault of recipient;
or
(b) is already known to recipient before receipt from the disclosing
party, as demonstrated by recipient's written records; or
(c) is made known to recipient by a third party who did not obtain it
directly or indirectly from the disclosing party and who does not obligate
recipient to hold it in confidence.
Specific information should not be deemed to be within any of these exclusions
merely because it is embraced by more general information falling within these
exclusions.
4.4 DISCLOSURES TO PERSONNEL: Recipient agrees to advise those of its
-------------------------
officers, directors, stockholders, employees, associates, agents, consultants,
AFFILIATES, and sublicensees who become aware of the Confidential Information,
of these
3
confidentiality and limited use obligations and agrees, prior to any disclosure
of Confidential Information to such individuals or entities, to make them bound
by obligations of confidentiality and limited use of the same stringency as
those contained in this AGREEMENT.
4.5 RETURN OF CONFIDENTIAL INFORMATION: Upon termination of this
-----------------------------------
AGREEMENT, originals and copies of Confidential Information in written or other
tangible form will be returned to the disclosing party by recipient or destroyed
by recipient. One copy of each document may be retained in the custody of the
recipient's legal counsel solely to provide a record of what disclosures were
made.
4.6 CONFIDENTIAL STATUS OF AGREEMENT: The terms of this AGREEMENT shall
---------------------------------
be deemed to be Confidential Information and shall be dealt with according to
the confidentiality requirements of this Article 4. Both parties agree,
furthermore, that neither party will make public disclosures concerning other
specific terms of this AGREEMENT without obtaining the prior written consent of
the other party, which consent shall not be unreasonably withheld.
ARTICLE 5 REPRESENTATION AND WARRANTIES
5.1 MONSANTO represents and warrants that it has the right to make
conveyances and grants in accordance with the articles hereof. MONSANTO further
warrants that at the date this Agreement is signed by MONSANTO, MONSANTO does
not know of any U.S. patent, whether or not owned or licensed to MONSANTO, which
would be infringed by the use or sale of LICENSED PRODUCTS other than LICENSED
PATENT RIGHTS. It is expressly understood, however, that in making the
conveyances and grants under this Agreement with the exception of the foregoing
provisions of this paragraph, MONSANTO MAKES NO REPRESENTATION, EXTENDS NO
WARRANTIES, EITHER EXPRESS OR IMPLIED, AND ASSUMES NO RESPONSIBILITIES
WHATSOEVER WITH RESPECT TO:
a) THE SCOPE OR VALIDITY OF ANY PATENT WHICH MAY FALL WITHIN
LICENSED PATENT RIGHTS; OR
b) ANY USE OF LICENSED PRODUCT BEING FREE FROM INFRINGEMENT OF
PATENTS OTHER THAN THE LICENSED PATENT RIGHTS.
ARTICLE 6 TERMINATION
6.1 Except as expressly provided otherwise, this Agreement shall terminate
upon reaching the TERM OF THIS AGREEMENT.
4
6.2 This Agreement may be terminated by NEWCO by giving MONSANTO thirty
(30) days prior written notice of its intention to terminate.
6.3 Except as provided in paragraph 6.2 , neither NEWCO nor MONSANTO may
terminate this Agreement unless the other party is in breach of this Agreement
and does not remedy such breach within thirty (30) days written notice of such
breach.
ARTICLE 7 PATENT LITIGATION
7.1 MONSANTO shall have power to institute and prosecute at its own
discretion and expense suits for infringement of the LICENSED PATENT RIGHTS.
All expenses in such suits will be borne entirely by MONSANTO, and MONSANTO
shall retain all judgements or awards arising from these suits.
7.2 If MONSANTO shall fail to commence suit on an infringement hereunder
within one (1) year after receipt of NEWCO's written request to do so, or at any
time MONSANTO so notifies NEWCO, NEWCO shall have the right to bring and
prosecute any such suits at its cost and expense through attorneys of its
selection, in its own name, and all sums received or recovered by NEWCO in or by
reason of such suits shall be retained by NEWCO; provided, however, NEWCO shall
have no such right during the time MONSANTO is prosecuting any infringement suit
in such country. In any such suit MONSANTO agrees to be joined as a party, if
necessary. Any costs to MONSANTO because of such suit brought by NEWCO, other
than any attorney fee paid by MONSANTO for its own representation, shall be
reimbursed by NEWCO.
ARTICLE 8 PATENT FILINGS AND PROSECUTION
8.1 MONSANTO shall be responsible for the filing, prosecuting and
maintaining any patent application relating to LICENSED PATENT RIGHTS, including
any foreign counterpart.
8.2 NEWCO shall be entitled to review and comment upon all actions
undertaken in the prosecution of all patents and applications. In the event
that MONSANTO decides to discontinue prosecution or maintenance of any patent or
patent application within LICENSED PATENT RIGHTS, it will notify NEWCO so that
NEWCO can assume the responsibility for prosecution or maintenance of such
patent or patent application at NEWCO's own costs.
5
ARTICLE 9 APPLICABLE LAW
9.1 THIS AGREEMENT SHALL BE CONSTRUED, INTERPRETED, AND GOVERNED BY THE
LAWS OF THE STATE OF MISSOURI, U.S.A. WITHOUT REGARD TO CONFLICTS OF LAW
PROVISIONS.
ARTICLE 10 MISCELLANEOUS PROVISIONS
10.1 NOTICES: All notices and other communications required or permitted
--------
under this AGREEMENT shall be deemed to be properly given when in writing and
sent by registered or certified mail, postage prepaid or by reputable courier
service or by telefax with receipt confirmation, to the other party at the
address set forth below, or at such other address as either party may in writing
designate from time to time for these purposes.
If to NEWCO: Calgene II, Inc.
0000 Xxxxx Xxxxxx
Xxxxx, Xxxxxxxxxx 00000
Attention: President
If to MONSANTO: Monsanto Company
000 Xxxxxxxxxxxx Xxxxxxx Xxxxx
Xx. Xxxxx, Xxxxxxxx 00000
Attention: President, Ceregen
Copy to: Monsanto Company
000 Xxxxx Xxxxxxxxx Xxxxxxxxx
Xx. Xxxxx, Xxxxxxxx 00000
Attention: Group Patent Counsel - A3SB
10.2 ASSIGNABILITY: The rights acquired herein by NEWCO are not
--------------
assignable in whole or part (by operation of law or otherwise) to any third
party, except to a successor to NEWCO's entire business, without the prior
written consent of MONSANTO. Any successor to NEWCO's entire business shall be
deemed bound by the terms of this AGREEMENT. Any transfer, assignment or
delegation made or attempted in violation of this subparagraph shall be void and
of no effect.
10.3 OTHER LICENSES: It is MONSANTO's present intention to minimize
---------------
licenses to others in the FIELD and to make commercially reasonable efforts to
limit licenses to others in the FIELD to those situations where it is beneficial
to MONSANTO in resolving patent issues and related business issues. However, it
shall remain solely in MONSANTO's discretion whether or not it will license
third parties who may directly compete with NEWCO.
6
In accordance with this AGREEMENT, the granting by MONSANTO of other non-
exclusive licenses in PRODUCE PLANTS to third parties shall be permitted.
10.4 SEVERABILITY: In case any one or more of the provisions contained in
-------------
this AGREEMENT shall for any reason be held invalid, illegal or unenforceable in
any respect, such invalidity, illegality or unenforceability shall not affect
any other provisions hereof, but this AGREEMENT shall be construed as if such
invalid or illegal or unenforceable provisions had never been contained herein.
10.5 COUNTERPARTS: This AGREEMENT may be executed in any number of
-------------
counterparts, each of which shall be an original with the same effect as if the
signatures thereto and hereto were upon the same instrument.
10.6 HEADINGS: Headings as to the contents of particular Articles are for
---------
convenience only and are in no way to be construed as part of this AGREEMENT or
as a limitation of the scope of the particular Articles to which they refer.
10.7 AGREEMENT REFERENCES: All paragraphs and subparagraphs referred to
---------------------
herein are paragraphs and subparagraphs of this AGREEMENT.
10.8 APPENDICES: The appended Appendices form an integral part of this
-----------
AGREEMENT.
10.9 EXPORT CONTROL: Notwithstanding any other provisions of this
---------------
AGREEMENT, NEWCO agrees to make no disclosure or use of any MONSANTO information
or MONSANTO technology furnished or made known to NEWCO pursuant to this
AGREEMENT, except in compliance with the laws and regulations of the United
States of America, including the Export Administration Regulations promulgated
by the Office of Export Administration International Trade Administration,
United States Department of Commerce; and in particular, NEWCO agrees not to
export, directly or indirectly, either
(a) the technical data furnished or made known to NEWCO pursuant to this
AGREEMENT; or
(b) the "direct product" thereof; or
(c) any commodity produced using such technical data
7
to any country or countries for which a validated license is required unless a
validated license is first obtained pursuant to the Export Administration
Regulations. The term "direct product" as used above, is defined to mean the
immediate product (including process and services) produced directly by the use
of the technical data.
10.10 FORCE MAJEURE:
--------------
(a) Except for payments of money, neither of the parties shall be
liable for any default or delay in performance of any obligation under this
AGREEMENT caused by any of the following: Act of God, war, riot, fire,
explosion, accident, flood, sabotage, compliance with governmental requests,
laws, regulations, orders or actions, national defense requirements or any other
event beyond the reasonable control of such party; or labor trouble, strike,
lockout or injunction (provided that neither of the parties shall be required to
settle a labor dispute against its own best judgment).
(b) The party invoking this subparagraph 10.10 shall give the other
party notice and full particulars of such force majeure event by telephone,
telegram, telex or telecopier as soon as possible after the occurrence of the
cause upon which said party is relying. Telephone, telegram, telex and
telecopier notices shall be confirmed in writing by the sending party within
five (5) days.
(c) Both MONSANTO and NEWCO shall use reasonable efforts to mitigate
the effects of any force majeure on their respective part.
10.11 NEGATION OF AGENCY: It is agreed and understood by the parties
-------------------
hereto that each of NEWCO and MONSANTO, in its performance of its obligations
and responsibilities under this AGREEMENT, is an independent contractor and that
nothing herein contained shall be deemed to create an agency, partnership, joint
venture or like relationship between the parties. The manner in which each of
NEWCO and MONSANTO carries out its performance under this AGREEMENT is within
each of NEWCO'S and MONSANTO'S sole discretion and control.
10.12 FURTHER ASSURANCES: The parties hereto agree that upon reasonable
-------------------
request of the other party, each such party shall execute and deliver such
additional documents and agreements, and take such further actions, as may be
necessary in order to fulfill and give effect to the terms of this Agreement.
8
IN WITNESS WHEREOF, the parties hereto have caused this AGREEMENT to be executed
and delivered as of the Effective Date.
CALGENE II, INC.
By:____________________
MONSANTO COMPANY
By:____________________
Xxxxxx X. Xxxxxx
President, Ceregen
9
APPENDIX A
Serial No. 809,457 filed 12-17-91
